Professionals 205 Users Online

Antifibrinolytic Drugs Market

Antifibrinolytic Drugs Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025

Antifibrinolytic Drugs Market Segmented By Drug Types such as Amicar, Aminocaproic acid, Aprotinin, Cyklokapron, Fibrinogen, human, Lysteda, RiaSTAP, Tranexamic acid injection, Tranexamic acid oral, Trasylol

Introduction

Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis.

Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein. Antifibrinolytic drugs have nearly a ubiquitous use during important major surgeries when bleeding is expected most likely. The inhibition of fibrinolytic pathway after the tissue injury has constantly been showing a decrease in postoperative bleeding this ultimately results in the reduction in need of blood transfusion after an operation.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Global Antifibrinolytic Drugs Market: Dynamics 

Growth in healthcare investments, the prevalence of angioedema and growing high-risk geriatric population, are the major factors driving the global market growth for angioedema treatment. In the next few years, the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan.  Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market. 

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Global Antifibrinolytic Drugs Market: Segmentation

On the basis of Indications
  • Gynecology
    • Menorrhagia
    • Pregnancy
    • Parturition
    • Gynecological surgery
    • Gastrointestinal (GI) bleeding
    • Dental surgery
    • Haemorrhage
    • Bleeding disorders
  • Hereditary angioedema
  • Fibrinolytic response testing
  • Surgeries
    • Cardiac
    • Orthopedic
    • Liver
    • Neurosurgery
On the basis of Drug Types
  • Amicar
  • Aminocaproic acid
  • Aprotinin
  • Cyklokapron
  • Fibrinogen, human
  • Lysteda
  • RiaSTAP
  • Tranexamic acid injection
  • Tranexamic acid oral
  • Trasylol
 On the basis of End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Healthcare Specialty processes
  • Others
On the basis of Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Global Antifibrinolytic Drugs Market: Region-wise Outlook

Geographically, North America is the dominating region in the Antifibrinolytic Drugs market owing to the advancing strict rules at the work place in this region, also due to a large number of aging population and broad technical applications of Antifibrinolytic Drugs in the region. Also, rising awareness of Antifibrinolytic Drugs has fueled the Antifibrinolytic Drugs market.The US holds the prominent market in the Antifibrinolytic Drugs market in North America trailed by Europe including Germany, France, and the UK.

The Asian market for Antifibrinolytic Drugs is also expected to witness a high CAGR during the coming years. Increased foreign investments in this region will also boost the Antifibrinolytic Drugs market ahead. China and Japan are projected to be the fastest-growing in the Antifibrinolytic Drugs market.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Global Antifibrinolytic Drugs Market: Key Players

Currently, the global Antifibrinolytic Drugs market is highly competitive owing to the involvement of many established players. Some of the key players in the global Antifibrinolytic Drugs market are Aurobindo Pharma Ltd, Acic Fine Chems, Akorn and Xanodyne Pharmaceuticals

- Companies Covered in This Report -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate